NEW YORK, NY / ACCESS Newswire / January 23, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ:BBNX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Beta Bionics and certain of its officers […]
Recognizing the top 7% of physicians and the healthcare organizations setting the standard for clinical excellence in 2026 NEW YORK CITY, NEW YORK / ACCESS Newswire / January 23, 2026 / Castle Connolly this week announced the release of the 2026 Top Doctors, Rising Stars, and Accolades recognizing the nation’s top physicians and healthcare organizations
NEW YORK CITY, NY / ACCESS Newswire / January 23, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Above Foods Ingredients Inc. ("Above Food" or the "Company") (NASDAQ:ABVE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Above Food and certain of
NEW YORK CITY, NY / ACCESS Newswire / January 23, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Sigma Lithium Corporation ("Sigma Lithium" or the "Company") (NASDAQ:SGML). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sigma Lithium and certain of its
Quicksburg, VA – AD Engineering is a trusted supplier of HVAC components, known for providing high-quality parts and essential materials to professionals in the industry. One of their key offerings is refrigerant line sets, which play an important role in the overall performance of HVAC systems. These line sets are responsible for transporting refrigerant between
NEW YORK CITY, NY / ACCESS Newswire / January 23, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. ("Zenas" or the "Company") (NASDAQ:ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Zenas and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / January 23, 2026 / Pomerantz LLP is investigating claims on behalf of investors of ETHZilla Corporation ("ETHZilla" or the "Company") (NASDAQ:ETHZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ETHZilla and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / January 23, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Apogee Enterprises, Inc. ("Apogee" or the "Company") (NASDAQ:APOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Apogee and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / January 23, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ:CORT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Corcept and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / January 23, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Insmed Incorporated ("Insmed" or the "Company") (NASDAQ:INSM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Insmed and certain of its officers and/or directors